Again...CONFUSING "pure-guesses" with "Proper-DD" is a

New Post Public Reply Private Reply Replies (0) Message Board
HHSErocks Dragonxbreath #7079
271
Again...CONFUSING "pure-guesses" with "Proper-DD" is a common mistake amongst OTC investors. Please allow me to explain the difference:

OTC companies are notorious for being low on cash and thus, experiencing delays. No one knows that better than the bashers and shorts who practically-live on the boards, making "guesses" and unfounded predictions. Guessing, predicting, extrapolating or relying on "past history" is not remotely in the category of "Proper-DD". History is only right until it's 100% wrong. Any chart will tell you that.

Proper DD entails asking the right questions, UNDERSTANDING the REASONS behind the delays, comprehending the available and logical solutions to resolve the problems and recover from the delays, and moving forward towards the finish line.

Constantly throwing out Guesses, saying "this and that won't happen...it will never happen, or won't happen this year or that year" is not even close to proper DD, and it's certainly not in the realm of actual Investing. Properly Monitoring (and understanding) the Process and the following the Progress is.

At least we know WHY those bashers and shorts do what they do. We understand their HOPE of demoralizing longs and keeping new investors away. They're just doing what's in THEIR best interest. I can respect that. They have certainly worked HARD for the past decade to do the things that support their own nefarious agenda.

But, for the life of me, I can't understand anyone with actual shares constantly shooting themselves in the foot. It's like when a robber breaks into your house and threatens your family with a gun, and you hand him a knife. Here you go Sir. Here is a sharp knife for you, just in case your gun jams or misfires. lol.

But all kidding aside, there is only ONE reason I can think of for your constant negativity (which definitely results from poor DD). It has to be a severe NEED to "be right". Therefore, you have found solace in trashing your own investment while remaining in a position to benefit from its success. WIN-WIN... i.e. IF (for some reason) HHSE doesn't work out, you get to say "I was right. I told you so"...and WHEN HHSE succeeds (as ALL signs point to), you get to GREATLY benefit with $millions. WIN-WIN.

I, personally, pick a side and stick to it (unless there is REAL REASON to adjust my thinking). I don't need to use that "DEFENSE MECHANISM" as a crutch.

However, I do understand that everyone is different, and some folks need to do whatever it takes for them to cope with the stresses of OTC investing. It's not easy. Certainly not for everyone. High Risk. High Reward.

Speaking of Rewards and "Guesses", I predict that your "fears" will cause you to miss out on PLENTY of profits. You will probably end up with only 5x or less from this investment, leaving the 50x and 100x on the table.

Again, that's just a guess, not Proper-DD.

Enjoy the ride. Best of luck to ALL longs.



 

Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Medtronic's $80M Bet: Pi-Cardia's Heart Tech

Updated Category News Views 2

Medtronic's Calculated Leap with Pi-Cardia Just when you think the world of healthcare technology quiets down, here comes Medtronic (NYSE: MDT) barreling in with a hefty $80 million strategic play in Pi-Cardia Ltd. This move is no mere feather in the cap; it’s a calculated maneuver to refresh and supercharge their structural heart portfolio. What are they really gunning...

Continue Reading
S4 Capital's Monks: Leading in Global Digital Marketing

Updated Category News Views 2

Monks: Leading the Charge with AI So, here's the deal with S4 Capital's Monks being named a Leader in the 2026 Gartner Magic Quadrant for Global Digital Marketing Agencies. If you're tuning your ear to the modern marketing game, this move is huge. The global digital-first marketing juggernaut known as Monks is setting quite the bar. They're weaving AI into every stitch of...

Continue Reading
Sceye's Stratospheric Leap: A Revolution in Connectivity

Updated Category News Views 0

Sceye's Game-Changer: Stratospheric Connectivity Breakthrough Every once in a while, a tech leap makes folks sit up straight. Maybe it's the allure of a new gadget or a mind-blowing application that spells out change in big, bold letters. Well, Sceye just lobbed one over the Pacific that's like a stone-cold revolution in the world of connectivity. Imagine a game of chess...

Continue Reading
Medtronic's $700M Move with Cornerstone Robotics

Updated Category News Views 3

Medtronic Dives Deeper into Robotic Surgery You've got to hand it to Medtronic. They know how to make a splash, this time by slinging $700 million to lock arms with Cornerstone Robotics. Now, why do you reckon a giant like Medtronic is shelling out that kind of cash? Simple—the robotic-assisted surgery sector is a goldmine waiting to be mined. So they’re strapping on...

Continue Reading
Immunic Paves Path with New Digital Leadership

Updated Category News Views 2

Shifting Gears: A Closer Look at Immunic's New Direction It's not every day you witness a biotech outfit like Immunic making waves with a high-profile leadership shift. Today, they introduced Chitrang Davé as their Chief Data and Digital Officer. Why's this a big deal? Well, it's a signal that Immunic is dead serious about stepping into commercial territory. The Role and...

Continue Reading
HRC Fertility Names New CMO to Propel Innovation Ahead

Updated Category News Views 3

Big Steps in Fertility Leadership at HRC HRC Fertility just shook up the playbook, appointing Dr. Robert Boostanfar as their new Chief Medical Officer. It's no walk in the park leading one of the nation's fertility giants. Boostanfar's been around the block with HRC, already a major player in shaping what they do, and now he's steering the ship with the title to match....

Continue Reading
Medtronic's Q1 2027 Surge Signals Promising Future

Updated Category News Views 2

Medtronic's Impressive Q1 2027: A Closer Look It's not every day you see a healthcare titan like Medtronic (NYSE: MDT) flex some serious muscle on the financial front. As the first quarter of fiscal year 2027 wrapped up, Medtronic delivered a knockout with a reported 13.7% increase in revenue, totaling a hefty $9.8 billion. This wasn't just luck—this was strategic...

Continue Reading
Nutex Health Breach: Legal Scrutiny and Risks Rise

Updated Category News Views 0

Cyberattack Unravels at Nutex Health Not just another day in the office for Nutex Health. The Houston-based micro-hospital operator, envisioned as a go-to for healthcare with its 28 facilities across 12 states, now finds itself plunged into a data nightmare. On August 24, 2026, they blew the whistle on unauthorized network activity. By August 31, it wasn’t just a minor...

Continue Reading
Panel Eyes AI, Guidelines for Workers' Comp Claims

Updated Category News Views 2

Tackling Workers' Comp Consistency The world of workers' comp is all set for a shake-up come National Comp 2026. With industry stalwarts gathering in Seattle, one hot topic on the table is how to turn evidence-based guidelines into everyday practice for claims. And, trust me, it's not as straightforward as slapping guidelines into a handbook. Evidence and Integration: A...

Continue Reading
SCO Agenda: Development, Security, and Global Equity

Updated Category News Views 2

China's Vision for a Balanced World In a world chock-full of friction and uncertainty, President Xi's proclamation at the recent SCO meeting has struck a chord. The SCO, once a fledgling idea among nations, now stands on the global stage with Xi's ringing call for it to prioritize development and equity in governance. A Subtle Shift in the Global South's Influence Xi's...

Continue Reading

Top 5 Most Recently Viewed Articles

Longeveron Inc. to Share Q1 2025 Financial Insights Soon

Updated Category News Views 177

Longeveron Inc. to Share Q1 2025 Financial Insights MIAMI -- Longeveron Inc. (NASDAQ: LGVN), a prominent player in the clinical stage regenerative medicine sector, is set to report its financial results for the first quarter of 2025. The announcement will take place on May 8, 2025, following the closing of U.S. financial markets. This report will be pivotal as it provides...

Continue Reading
Investors Urged to Take Action in Five Below Securities Case

Updated Category News Views 173

Five Below faced serious allegations back in 2024, with whispers of securities fraud echoing through the trading floors. Investors who bought shares during the specified class period might have been misled by rosy projections that didn’t pan out. As the dust settled, it became clear: those once-promising forecasts weren’t just off—they were completely misleading....

Continue Reading
YolTech Therapeutics Advances YOLT-201 in Groundbreaking Trial

Updated Category News Views 348

YolTech Therapeutics Advances Forward with YOLT-201 YolTech Therapeutics has made significant strides in the field of gene editing with their innovative therapy, YOLT-201, designed to treat patients suffering from ATTR amyloidosis. The company has recently announced the successful completion of the dose escalation phase in their ongoing Phase I/IIa clinical trial. Trial...

Continue Reading
AT&T Webcast with John Stankey: Insights from Goldman Sachs

Updated Category News Views 74

AT&T to Host a Webcast Featuring John Stankey at Goldman Sachs Conference Get ready to join John Stankey, the CEO of AT&T Inc. (NYSE: T), as he engages in an insightful fireside chat at the upcoming Goldman Sachs Communacopia + Technology Conference. Be sure to mark your calendars for this important event, where you can hear directly from one of the industry's top...

Continue Reading
Good Vibes Club Partners with Instant IP to Elevate Digital Presence

Updated Category News Views 137

Good Vibes Club and Instant IP Forge Strategic Partnership Good Vibes Club (GVC), a leading NFT project of recent times, has announced a significant collaboration with Instant IP, an innovative solution specializing in blockchain-based intellectual property protection. This partnership aims to solidify GVC's standing in a rapidly evolving digital economy, where the value...

Continue Reading